Breaking News Instant updates and real-time market news.

UROV

Urovant Sciences

$8.35

0.41 (5.16%)

04:55
04/25/19
04/25
04:55
04/25/19
04:55

Urovant Sciences management to meet with JMP Securities

Meetings to be held in Texas on April 23 in Denver on April 24 in San Francisco April 25 hosted by JMP Securities.

  • 25

    Apr

UROV Urovant Sciences
$8.35

0.41 (5.16%)

03/15/19
RHCO
03/15/19
INITIATION
Target $24
RHCO
Buy
Urovant Sciences initiated with a Buy at SunTrust
SunTrust analyst Edward Nash initiated Urovant with a Buy rating and a price target of $24, saying the stock offers a "compelling risk-reward" and the possibility of a strong near-term data readout from its pivotal Phase III EMPOWUR trial for vibegron later this month. The analyst cites his conviction for a positive readout in patients with overactive bladder based on the approval of vibegron in Japan and also points to Astellas' Myrbetriq, which is a drug from the same class as that of Urovant, being commercially available in the U.S. since 2012. Nash sees vibegron total revenue potential for the company of as much as $2.8B by 2032.
03/15/19
03/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Simmons First National (SFNC) initiated with a Buy at DA Davidson. 2. Amgen (AMGN) and Gilead (GILD) initiated with an Outperform at BMO Capital. 3. Rocket Pharmaceuticals (RCKT) initiated with a Buy at BofA/Merrill. 4. Urovant Sciences (UROV) initiated with a Buy at SunTrust. 5. Spectrum (SPPI) assumed with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/19
JPMS
03/20/19
NO CHANGE
Target $24
JPMS
Overweight
JPMorgan boosts Urovant target to $24, calls selloff yesterday unfounded
JPMorgan analyst Eric Joseph raised his price target for Urovant Sciences to $24 from $20 saying he views the Empowur data, "showing clear and early separation from placebo across all primary and secondary endpoints, as a key de-risking event for the program." The data support "best-in-class commercial" for vibegron in overactive bladder, Joseph tells investors in a research note. The analyst views yesterday's stock pullback as unfounded and sees an attractive entry point at current share levels. He keeps an Overweight rating on Urovant Sciences.
03/20/19
COWN
03/20/19
NO CHANGE
Target $25
COWN
Outperform
Urovant's vibegron data present clear path to approval, says Cowen
After Urovant Sciences announced top-line results from the Phase 3 study of Vibegron in adults with overactive bladder, Cowen analyst Ritu Baral called the results "extremely positive" and contends they present a clear path to approval. She also believes the data set up a "compelling marketing strategy" built around a superior clinical profile, Baral tells investors. She maintains an Outperform rating on Urovant shares with a $25 price target.

TODAY'S FREE FLY STORIES

ICAGY

IAG

$0.00

(0.00%)

05:03
06/19/19
06/19
05:03
06/19/19
05:03
Downgrade
IAG rating change  »

IAG downgraded to Reduce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESYJY

easyJet

$0.00

(0.00%)

05:02
06/19/19
06/19
05:02
06/19/19
05:02
Downgrade
easyJet rating change  »

easyJet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFLYY

Air France-KLM

$0.00

(0.00%)

05:01
06/19/19
06/19
05:01
06/19/19
05:01
Downgrade
Air France-KLM rating change  »

Air France-KLM downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$102.20

1.8 (1.79%)

05:00
06/19/19
06/19
05:00
06/19/19
05:00
Downgrade
Mirati Therapeutics rating change  »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFNNY

Infineon

$0.00

(0.00%)

04:57
06/19/19
06/19
04:57
06/19/19
04:57
Initiation
Infineon initiated  »

Infineon initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

04:56
06/19/19
06/19
04:56
06/19/19
04:56
Downgrade
Energizer rating change  »

Energizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JSTTY

Just Eat

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Downgrade
Just Eat rating change  »

Just Eat downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
06/19/19
06/19
04:55
06/19/19
04:55
General news
Breaking General news story  »

FOMC Forecasts to be…

WMT

Walmart

$109.66

0.51 (0.47%)

, IPAR

Inter Parfums

$66.80

0.51 (0.77%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Jefferies to hold a conference »

2019 Global Consumer…

WMT

Walmart

$109.66

0.51 (0.47%)

IPAR

Inter Parfums

$66.80

0.51 (0.77%)

PG

Procter & Gamble

$109.60

-1.385 (-1.25%)

VGR

Vector Group

$9.61

-0.21 (-2.14%)

CHDN

Churchill Downs

$115.82

1.71 (1.50%)

CLUB

Town Sports

$2.41

-0.09 (-3.60%)

IGT

International Game

$13.62

0.5 (3.81%)

TACO

Del Taco

$11.44

0.11 (0.97%)

WYND

Wyndham Destinations

$42.93

0.18 (0.42%)

VAC

Marriott Vacations

$98.69

1.46 (1.50%)

KIM

Kimco Realty

$18.99

-0.02 (-0.11%)

AEO

American Eagle

$17.69

-0.27 (-1.50%)

LOCO

El Pollo Loco

$10.94

-0.11 (-1.00%)

BJ

BJ's Wholesale

$25.09

0.3 (1.21%)

TCX

Tucows

$61.30

-0.01 (-0.02%)

COT

Cott Corp.

$13.88

0.02 (0.14%)

CRMT

America's Car-Mart

$84.97

-1.62 (-1.87%)

DG

Dollar General

$137.03

1.18 (0.87%)

NUS

Nu Skin

$50.47

0.815 (1.64%)

CHEF

Chefs' Warehouse

$33.84

0.11 (0.33%)

HLF

Herbalife Nutrition

$43.87

0.83 (1.93%)

OLLI

Ollie's Bargain Outlet

$92.00

-0.32 (-0.35%)

SPTN

SpartanNash

$11.42

0.1 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 25

    Jul

  • 15

    Aug

  • 13

    Nov

GFN

General Finance Corp

$8.19

0.27 (3.41%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
General Finance Corp management to meet with Craig-Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

SEEL

Seelos Therapeutics

$2.26

0.075 (3.44%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Seelos Therapeutics management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

IBTX

Independent Bank

$54.77

1.26 (2.35%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Independent Bank management to meet with Sandler ONeill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 26

    Aug

SMG

Scotts Miracle-Gro

$98.13

1.24 (1.28%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Scotts Miracle-Gro management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 21

    Jun

CSV

Carriage Services

$19.34

-0.03 (-0.15%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Carriage Services management to meet with Sidoti »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 25

    Jun

BAM

Brookfield

$47.97

0.82 (1.74%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Brookfield management to meet with TD Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 08

    Aug

SNV

Synovus

$33.69

0.98 (3.00%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Synovus management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

BIG

Big Lots

$29.68

0.25 (0.85%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Big Lots management to meet with Loop Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

REED

Reed's

$3.66

-0.05 (-1.35%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Reed's management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

RVNC

Revance

$11.48

0.18 (1.59%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Revance management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 10

    Jul

  • 11

    Jul

SRI

Stoneridge

$30.15

0.76 (2.59%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Stoneridge management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 13

    Nov

CECE

CECO Environmental

$8.96

0.1 (1.13%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
CECO Environmental management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 25

    Jun

NOG

Northern Oil and Gas

$2.13

0.09 (4.41%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Northern Oil and Gas management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

SRCL

Stericycle

$45.49

-0.44 (-0.96%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Stericycle management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 21

    Aug

XEL

Xcel Energy

$60.09

0.25 (0.42%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Utilities Technology Council to hold a conference »

UTC Telecom &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPG

Washington Prime

$4.17

0.14 (3.47%)

04:55
06/19/19
06/19
04:55
06/19/19
04:55
Conference/Events
Washington Prime management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.